ARDIŞIK HAM(S-HAM) PROTOKOLÜ

Kaynaklar:

1- Braess, J., Amler, S., Kreuzer, KA. et al. Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study. Leukemia 32, 2558–2571 (2018).

2- Kern W, Aul C, Maschmeyer G, Kuse R, Kerkhoff A, Grote-Metke A, et al. Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group. Ann Hematol. 1998;77: 115–22.

3- Castaigne S, Chevret S, Archimbaud E, Fenaux P, Bordessoule D, Tilly H, et al. Randomized comparison of double induction and timed-sequential induction to a “3+7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study. Blood. 2004;104:2467–74.